Clinical Trials
11 trialsNCT05256225 2026-05-27
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
Phase 3 Recruiting
NCT04092270 2026-05-13
A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT06962995 2026-04-06
Multi-Cancer Detection Observational Cohort Study
Mayo Clinic
Recruiting
NCT07131007 2026-03-23
Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics
Hebei Medical University Fourth Hospital
Recruiting
NCT04706481 2026-03-12
Archival of Human Biological Samples in CU-Med Biobank
Chinese University of Hong Kong
Recruiting
NCT05746169 2025-12-30
Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health
University of California, San Francisco
Terminated
NCT06207864 2025-11-13
PE-CGS
New Mexico Cancer Research Alliance
Phase NA Recruiting
NCT06832150 2025-02-18
SMS2
The Wellcome Sanger Institute
Enrolling by invitation
NCT06584877 2024-09-05
Investigating How Childhood Tumours and Congenital Disease Develop
The Wellcome Sanger Institute
Enrolling by invitation
NCT06584994 2024-09-05
Investigating the Role of Genetics in Disease Predisposition
The Wellcome Sanger Institute
Enrolling by invitation
NCT02595866 2024-08-09
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
National Cancer Institute (NCI)
Phase 1 Completed